Clinical trial
The Efficacy and Safety of ITF2357 in AIS
NCT00442182 · Radboud University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00442182 |
|---|---|
| Title | The Efficacy and Safety of ITF2357 in AIS |
| Official title | The Effects and Side Effects of ITS2357 in Autoinflammatory Syndromes |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autoinflammatory Syndromes, HIDS, TRAPS, Schnitzler's Syndrome |
| Intervention type | Drug |
| Interventions | ITF2357 |
| Enrollment | 20 |
| Start date | Sep 1, 2006 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 1, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: